المؤلفون: Güzelbulut, Fatih, Gökçen, Pınar, Can, Güray, Adalı, Gupse, Saltürk, Ayça Gökçen Değirmenci

المساهمون: BAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, orcid:0000-0003-4889-208X, orcid:0000-0003-2157-0304, orcid:0000-0002-6054-9244, Can, Güray

مصطلحات موضوعية: Long-Term Entecavir, Disoproxil Fumarate, Lamivudine, Therapy

وصف الملف: application/pdf

Relation: Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; Turkish Journal of Gastroenterology; Güzelbulut, F., Gökçen, P., Can, G., Adalı, G., Saltürk, A. G. D., Aslan, E., . & Doğanay, H. L. (2021). Comparison of the efficacy of entecavir and tenofovir in reducing hepatocellular carcinoma risk in chronic hepatitis B patients: a real-life study in Turkey. The Turkish Journal of Gastroenterology, 32(4), 412.; PUBMED ID: 34231488; http://dx.doi.org/10.5152/tjg.2021.20423; https://hdl.handle.net/20.500.12491/11401; 32; 412; 421

الاتاحة: https://hdl.handle.net/20.500.12491/11401
https://doi.org/10.5152/tjg.2021.20423

المؤلفون: Xie, Yan-Di, Ma, Hui, Feng, Ba, Wei, Lai

المساهمون: Wei, L (reprint author), Peking Univ, Peoples Hosp, Beijing Key Lab Hepatitis & Immunotherapy Liver D, Hepatol Inst, Beijing 100044, Peoples R China., Peking Univ, Peoples Hosp, Beijing Key Lab Hepatitis & Immunotherapy Liver D, Hepatol Inst, Beijing 100044, Peoples R China.

المصدر: 万方 ; SCI ; http://d.g.wanfangdata.com.cn/Periodical_zhcmj201718008.aspx

مصطلحات موضوعية: Entecavir, Hepatitis B Virus, Partial Virological Response, Primary Nonresponse, Real-world, Virological Response, POSITIVE CHRONIC HEPATITIS, CLINICAL-PRACTICE GUIDELINES, LONG-TERM ENTECAVIR, HEPATOCELLULAR-CARCINOMA, E-ANTIGEN, ADEFOVIR DIPIVOXIL, VIRAL SUPPRESSION, NATURAL-HISTORY, LAMIVUDINE

Relation: CHINESE MEDICAL JOURNAL.2017,130(18),2190-2197.; 1904830; http://hdl.handle.net/20.500.11897/470805; WOS:000409375900008

الاتاحة: https://hdl.handle.net/20.500.11897/470805
https://doi.org/10.4103/0366-6999.213969

المؤلفون: Xu, J.H., Wang, S., Xu, Z.N., Yu, Y.Y., Si, C.W., Zeng, Z., Li, J., Mao, Q., Zhang, D.Z., Tang, H., Sheng, J.F., Chen, X.Y., Ning, Q., Shi, G.F., Xie, Q., Zhang, X.Q., Dai, J.

المساهمون: Yu, YY (reprint author), Peking Univ, Dept Infect Dis, Ctr Liver Dis, Hosp 1, Beijing, Peoples R China., Peking Univ, Dept Infect Dis, Ctr Liver Dis, Hosp 1, Beijing, Peoples R China., Jiangsu Chia Tai Tianqing Pharmaceut Co Ltd, Nanjing, Jiangsu, Peoples R China., Nanjing Med Univ, Affiliated Hosp 1, Dept Infect Dis, Nanjing, Jiangsu, Peoples R China., Southwest China Hosp, Dept Infect Dis, Chongqing, Peoples R China., Chongqing Med Univ, Dept Infect Dis, Affiliated Hosp 2, Chongqing, Peoples R China., West China Hosp, Dept Infect Dis, Chengdu, Peoples R China., Zhejiang Univ, Affiliated Hosp 1, Dept Infect Dis, Hangzhou, Zhejiang, Peoples R China., Capital Med Univ, Beijing Youan Hosp, Dept Int Med, Beijing, Peoples R China., Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept & Inst Infect Dis, Wuhan, Peoples R China., Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai, Peoples R China., Jiaotong Univ, Sch Med, Ruijin Hosp, Dept Infect Dis, Shanghai, Peoples R China.

المصدر: SCI

مصطلحات موضوعية: chronic hepatitis B, entecavir maleate, randomized controlled trial, treatment outcome, CLINICAL-PRACTICE GUIDELINES, LONG-TERM ENTECAVIR, NAIVE PATIENTS, THERAPY, MANAGEMENT, RESISTANCE, LAMIVUDINE, INFECTION, ANTIGEN

Relation: JOURNAL OF VIRAL HEPATITIS.2017,24(10),877-884.; 1904712; http://hdl.handle.net/20.500.11897/470691; WOS:000409505700009

الاتاحة: https://hdl.handle.net/20.500.11897/470691
https://doi.org/10.1111/jvh.12710